Electrosurgical debulking of pretibial myxedema of the foot

Erisa Alia, Eric J. Feit, Jacob Oren Levitt

Research output: Contribution to journalArticlepeer-review

4 Scopus citations


Pretibial myxedema or thyroid dermopathy constitutes dermal deposition of mucin, primarily hyaluronic acid and chondroitin sulfate. It is a manifestation of autoimmune thyroiditis, seen more in Graves disease than in Hashimoto thyroiditis. The time delay from treatment of hyperthyroidism to appearance of localized myxedema varies from one month to 16 years (mean 5.13 years). Despite a variety of therapeutic options, failure and relapse rates are high. Therapeutic options reported in the literature include compression, topical and intralesional corticosteroids, oral pentoxifylline, octreotide, rituximab, plasmapheresis, and high-dose intravenous immunoglobulin. We share our experience in two patients who were treated with electrosurgical debulking of selected longstanding myxedematous lesions, with one positive result and one negative result.

Original languageEnglish
Article number15
JournalDermatology Online Journal
Issue number2
StatePublished - 2019


  • Electrosurgery
  • Electrosurgical debulking
  • Elephantiasic pretibial myxedema
  • Graves disease
  • Pretibial myxedema


Dive into the research topics of 'Electrosurgical debulking of pretibial myxedema of the foot'. Together they form a unique fingerprint.

Cite this